Approvals
Devices
Diagnostics
Manufacturing
Medicines
Pharma
Pricing
Therapies
The Presidency of the Council
From the magazine
Magazine · Issue 01 · Made in Europe
The latest approvals in Europe
Between March and September, Europe cleared 41 new medicines and a new class of AI-driven diagnostics. European companies led just over half, yet the first-of-their-kind treatments still belong mostly to rare diseases and specialist cancers.
Magazine · Issue 01 · Made in Europe
Jascayd
The story behind a key 2026 EU authorisation, told by the Boehringer Ingelheim teams who spent more than twenty-five years on it.
Magazine · Issue 01 · Made in Europe
Play at home, win at home
Europe knows how to grow biotech champions. Søren Møller has helped build more than thirty of them, companies that raise billions and reach global markets. Almost all stage their payday on a US exchange. The managing partner of Novo Holdings’ Seed Investments team has cracked the method. The task now is to back them and keep them home.